inflammatory bowel disease treatment market
Pharmaceuticals

How Will The Inflammatory Bowel Disease Treatment Market Globally Expand In 2023?

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s inflammatory bowel disease treatment market report forecasts the inflammatory bowel disease treatment market size to grow to $25.74 Billion by 2027, with a CAGR (compound annual growth rate) of more than 4%.

Learn More On The Inflammatory Bowel Disease Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Inflammatory Bowel Disease Treatment Market Size Forecast
The global inflammatory bowel disease treatment market is expected to grow from $20.39 billion in 2022 to $21.3 billion in 2023 at a compound annual growth rate (CAGR) of 4.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The inflammatory bowel disease treatment market size is expected to grow to $25.74 billion in 2027 at a CAGR of 4.8%.

North America held the largest inflammatory bowel disease treatment market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Inflammatory Bowel Disease Treatment Market Driver ­– Rise In The Prevalence Of Crohn’s Disease And Ulcerative Colitis
For instance, according to March 2022 research published in the United States National Library of Medicine, a US-based medical library, around 1.6 million Americans currently suffer from inflammatory bowel disease (Crohn’s disease or ulcerative colitis) and around 70,000 new cases of IBD are diagnosed every year in the USA. Hence, the rising prevalence of Crohn’s disease and ulcerative colitis is expected to drive the inflammatory bowel disease treatment market.

Request for A Sample Of The Global Inflammatory Bowel Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

Key Inflammatory Bowel Disease Treatment Market Trend – Technological Advancement
The key players in the inflammatory bowel disease treatment market are focusing on using technology such as artificial intelligence (AI) for the drug discovery process as well as offering advanced but new inflammatory bowel disease treatments. To attain their technological innovations, key players and technology companies are partnering to leverage each other’s competencies and technology to develop new treatments and strengthen their key position in the market. For instance, in May 2021, CytoReason, an Israeli technology start-up developing a computational model of the human body, partnered with Ferring Pharmaceuticals, a Switzerland-based multinational pharmaceutical company to develop new inflammatory bowel disease treatments (IBD) using artificial intelligence technology during the drug discovery process. Ferring’s medical expertise will be combined with CytoReason’s artificial intelligence (AI) technology to create cell-centred illness models. The AI technology enables scientists to gain critical information on the body’s functioning and treats diseases at the cellular level.

Inflammatory Bowel Disease Treatment Market Segment
1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes
2) By Type: Crohn’s Disease, Ulcerative Colitis
3) By Route of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Inflammatory Bowel Disease Treatment Market Major Players and Strategies
Major players in the inflammatory bowel disease treatment market are AbbVie Inc., Biogen, Johnson & Johnson, Amgen Inc., UCB SA, Novartis AG, Takeda Pharmaceutical Company Limited, Merck & Co, Pfizer Inc., Abbott Laboratories, Janssen Biotech Inc., Eli Lilly, Allergan plc, Alkem Laboratories Limited, and Bausch Health Companies Inc.

In March 2022, Pfizer, Inc., a US-based pharmaceutical and biotechnology company, acquired Arena Pharmaceuticals, Inc., for an amount of $6.7 billion. Through this acquisition, Pfizer will increase its Inflammation and Immunology therapeutic area research capabilities, develop therapies for treatment of immuno-inflammatory diseases, and continue the clinical development of current drug candidates. Arena Pharmaceuticals, Inc., is a US-based biopharmaceutical company specializing in the development of novel prospective treatments for the treatment of various immuno-inflammatory illnesses.

The Inflammatory Bowel Disease Treatment Global Market Report 2023 covers regional data on inflammatory bowel disease treatment market size, inflammatory bowel disease treatment market trends and drivers, opportunities, strategies, and inflammatory bowel disease treatment market competitor analysis. The countries covered in the inflammatory bowel disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Inflammatory bowel disease treatment refers to anti-inflammatory medications that are commonly used to treat mild to moderate ulcerative colitis. Aminosalicylates such as mesalamine (Delzicol, Rowasa, and other brands), balsalazide (Colazal), and olsalazine are anti-inflammatories (Dipentum).

View More Reports Related To The Inflammatory Bowel Disease Treatment Market –
Hyperphosphatemia Treatment Global Market Report 2023
Non-Steroidal Anti-Inflammatory Drugs Global Market Report 2023
Digestive Health Supplements Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: